Although significant numbers of children with learning or behavioral disorders may be receiving psychopharmacologic medications, special education personnel may not always be familiar with either specific therapeutic effects or side effects of such drugs. The following is a brief introduction to specific classroom issues involved in the four major classes of psychotropic medication, along with certain recent methodological concerns in both research and classroom intervention in this area.
Get full access to this article
View all access options for this article.
References
1.
Abikoff, H., & Gittelman, R. (1985). Hyperactive children treated with stimulants: Is cognitive training a useful adjunct?Archives of General Psychiatry, 42, 953–961.
2.
Aman, M.G. (1980). Psychotropic drugs and learning problems: A selective review. Journal of Learning Disabilities, 13, 89–97.
3.
Aman, M.G., & Singh, N.N. (1980). The usefulness of thioridazine for treating childhood disorders—Fact or folklore?American Journal of Mental Deficiency, 84, 331–338.
4.
Barkley, R.A. (1979). Using stimulant drugs in the classroom. School Psychology Digest, 8, 412–425.
5.
Barkley, R.A. & Cunningham, C.E. (1978). Do stimulant drugs improve the academic performance of hyperactive children?Clinical Pediatrics, 17, 85–92.
6.
Barkley, R.A., & Cunningham, C.E. (1979a). The effects of methylphenidate on the mother-child interactions of hyperactive children. Archives of General Psychiatry, 36, 201–208.
7.
Barkley, R.A., & Cunningham, C.E. (1979b). Stimulant drugs and activity level in hyperactive children. American Journal of Orthopsychiatry, 49, 491–499.
8.
Biederman, J., & Jelliner, M.S (1983). Current concepts: Psychopharmacology in children. New England Journal of Medicine, 308, 968–972.
9.
Campbell, M., Anderson, L., Meier, M., Cohen, I., & Small, A. (1978). A comparison of haloperidol and behavioral therapy and their interaction in autistic children. Journal of Child Psychiatry, 17, 640–655.
10.
Campbell, M., Small, A.M., Green, W.H., Jennings, S.J., Perry, R., Bennett, W.G., & Anderson, L. (1984). Behavioral efficacy of haloperidol and lithium carbonate: A comparison in hospitalized aggressive children with conduct disorder. Archives of General Psychiatry, 120, 650–656.
11.
Cantwell, D.P., & Carlson, G.A. (1978). Stimulants. In J.S. Werry (Ed.), Pediatric psychopharmacology: The use of behavior modifying drugs in children (pp. 171–207). New York: Brunner/Mazel.
12.
Cantwell, D.P., & Carlson, G. (1983). Affective disorders in childhood and adolescence: An update. Jamaica, NY: SP Medical and Scientific Books.
13.
Conners, C.K. (1973). Rating scales for use in drug studies with children. Psychopharmacology Bulletin [Special Issue: Pharmacology of Children], 24–84.
14.
Dreifuss, F.E. (1983). Pediatric epileptology. Littleton, MA: John Wright PSG.
15.
Englehardt, D.M., & Polizos, P. (1978). Adverse effects of pharmacotherapy in childhood psychosis. In M.A. Lipton, A. DiMascio, & K.F. Killam (Eds.), Psychopharmacology: A generation of progress (pp. 1463–1469). New York: Raven Press.
16.
Englehardt, D.M., Polizos, P., Waizer, J., & Hoffman, S.P. (1973). A double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children. Journal of Autism and Childhood Schizophrenia, 3, 128–137.
17.
Epstein, M.H.Cullinan, D., & Lloyd, J. (1986). Behavior problem patterns among the learning disabled: III—Replication across age and sex. Learning Disability Quarterly, 9, 43–54.
18.
Essman, W.B. (1983). Clinical pharmacology of learning and memory. Jamaica, NY: SP Medical & Scientific Books.
19.
Fish, B. (1971). The “one child, one drug” myth of stimulants in hyperkinesis. Archives of General Psychiatry, 25, 193–203.
20.
Forness, S. (1983). Classroom observation: A procedures manual for gathering research or clinical data on children in ongoing classroom situations. Culver City, CA: Bradley Products.
21.
Forness, S., Campana, K., Akiyama K., & Seraydarian, A. (1984, November). Antidepressant medication: A preliminary study of classroom observation effects. Paper presented at the meeting of the Council for Children with Behavior Disorders, Tempe, AZ.
22.
Gadow, K.D. (1982). School involvement in the treatment of seizure disorders. Epilepsia, 23, 215–224.
23.
Gadow, K.D. (1983). Effects of stimulant drugs on academic performance in hyperactive and learning disabled children. Journal of Learning Disabilities, 16, 290–299.
24.
Gadow, K.D. (1983). Children on medication (Volumes I and II). San Diego: College-Hill Press.
25.
Garfinkel, B.D., Wender, P., Sloman, L., & O'Neill, I. (1983). Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children. Journal of Child Psychiatry, 22, 343–348.
26.
Gittelman, R., & Kanner, A. (1986). Psychopharmacology. In H. Quay & J. Werry (Eds.), Psychopathological disorders of childhood (3rd ed.). New York: Wiley.
27.
Gittelman, R., Klein, D.F., Abikoff, H., Katz, S., Pollack, E., & Mattes, J. (1980). A controlled trial of behavior modification and methylphenidate in hyperactive children. In C. Whalen & B. Henker (Eds.), Hyperactive children: The social ecology of identification and treatment (pp. 241–243). New York: Academic Press.
28.
Gittelman, R., Klein, D., & Feingold, I. (1983). Children with reading disorders—II. Effects of methylphenidate in combination with reading remediation. Journal of Child Psychology and Psychiatry, 24, 193–212.
29.
Gittelman-Klein, R., Klein, D.F., Katz, S., Saraf, K., & Pollack, E. (1976). Comparative effects of methylphenidate and thioridazine in hyperkinetic children. Archives of General Psychiatry, 33, 1217–1231.
30.
Gualtieri, C.T., Quade, D., Hicks, R.E., Mayo, J.P., & Schroeder, S.R. (1984). Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. American Journal of Psychiatry, 141, 20–23.
31.
Gualtieri, C.T., Wargin, W., Kanoy, R., Patrick, K., Shen, D., Youngblood, W., Mueller, R.A., & Breese, G.R. (1982). Clinical studies of methylphenidate serum levels in children and adults. Journal of the American Academy of Child Psychiatry, 21, 19–26.
32.
Kavale, K. (1982). The efficacy of stimulant drug treatment for hyperaativity: A meta analysis. Journal of Learning Disabilities, 15, 280–289.
33.
Kavale, K., & Forness, S. (1985). The science of learning disabilities. San Diego: College-Hill Press.
34.
Kavale, K.A., & Nye, C. (1984). The effectiveness of drug treatment for severe behavior disorders: A meta-analysis. Behavioral Disorders, 9, 117–130.
35.
Klein, D.F., & Gittelman, R., Quitkin, F., & Rifkin, A. (1980). Diagnosis and drug treatment of psychiatric disorders: Adults and children (2nd ed.). Baltimore: Williams & Wilkins.
36.
Kupietz, S.S., Winsberg, B.G., & Sverd, J. (1982). Learning ability and methylphenidate (Ritalin) plasma concentration in hyperkinetic children. Journal of the American Academy of Child Psychiatry, 21, 27–30.
37.
Livingston, S. (1978a). Medical treatment of epilepsy: Part I. Southern Medical Journal, 71, 298–310.
38.
Livingston, S. (1978b). Medical treatment of epilepsy: Part II. Southern Medical Journal, 71, 432–437.
39.
Mattison, R.E., Humphrey, F.J., Kales, S.N., Handford, A., Finkenbinder, R., & Hemit, R.C. (1986). Psychiatric background and diagnosis of children evaluated for special class placement. Journal of Child Psychiatry, 25, 514–520.
40.
O'Leary, K.D. (1980). Pills or skills for hyperactive children. Journal of Applied Behavior Analysis, 13, 191–204.
41.
Pelham, W.E. (1986). The effects of psychostimulant drugs on learning and academic achievement in children with attention-deficit disorders and learning disabilities. In J. Torgesen & B. Wong (Eds.), Psychological and educational perspectives on learning disabilities (pp. 160–168). New York: Academic Press.
42.
Platt, J.E. (1983). Cognitive effects of lithium carbonate and haloperidol in treatment resistant aggressive children. Unpublished manuscript, New York University Medical Center.
43.
Puig-Antich, J., Perel, J.M., Lupatkin, W., Chambers, W.J., Shea, C., Tabrizi, M.A., & Stiller, R.L. (1979). Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical reponse in prepubertal major depressive disorder. Journal of Child Psychiatry, 18, 616–627.
44.
Rapoport, J.L. (1978). Clinical assessment for pediatric psychopharmacology. In M.A. Lipton, A. DiMascio, & K.F. Killam (Eds.), Psychopharmacology: A generation of progress (pp. 112–120). New York: Raven Press.
45.
Reynolds, E.H. (1983). Mental effects of antiepileptic medication: A review. Epilepsia, 24 (Suppl. 2), 85–95.
46.
Siassi, I. (1982). Lithium treatment of impulsive behavior in children. Journal of Clinical Psychiatry, 43, 482–484.
47.
Sleator, E.K., & Sprague, R.L. (1978). Pediatric pharmacotherapy. In W.G. Clark & J. del Guidice (Eds.), Principles of psychopharmacology (2nd ed., pp. 573–591). Orlando, FL: Academic Press.
48.
Swanson, J., Kinsbourne, M., Roberts, W., & Zucker, K. (1978). Time response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics, 61, 21–29.
49.
Thompson, V.P., Gickling, E.E., & Havertape, J.F. (1983). The effects of medication and curriculum management on task-related behaviors of attention deficit disordered and low achieving peers. Monographs in Behavior Disorders, 6, 86–97.
50.
Trimble, M. (1979). The effect of anticonvulsant drugs on cognitive abilities. Pharmacology and Therapeutics, 4, 677–685.
51.
Weiss, G. (1981). Controversial issues of the pharmacotherapy of the hyperactive child. Canadian Journal of Psychiatry, 26, 385–392.
52.
Werry, J.S., & Aman, M.G. (1975). Methylphenidate and haloperidol in children: Effects on attention, memory, and activity. Archives of General Psychiatry, 32, 790–795.
53.
Werry, J.S., Aman, M.G., & Lampen, E. (1976). Haloperidol and methylphenidate in hyperactive children. Acta Paedopsychiatrica, 42, 26–40.
54.
Whalen, C.K., Henker, B., & Dolemoto, S. (1980). Methylphenidate and hyperactivity: Effects on teacher behaviors. Science, 208, 1280–1282.
55.
Williams, D.T. (1982). The effect of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction. Journal of Child Psychiatry, 21, 129–135.
